Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bioavailability of oral ciprofloxacin tablets versus suspension in pediatric cancer patients

Trial Profile

Bioavailability of oral ciprofloxacin tablets versus suspension in pediatric cancer patients

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Acronyms BioCip
  • Sponsors Erasmus MC
  • Most Recent Events

    • 21 Sep 2017 Status changed from recruiting to discontinued.
    • 06 Feb 2014 New source identified and integrated (European Clinical Trial Register, EudraCT2013-002744-89)
    • 30 Jan 2014 Status changed from not yet recruiting to recruiting as reported by European Clinical Trial register
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top